Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

18
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
18
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

26
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
26
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

24
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
24
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

32
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
32
Aneurysm I: Introduction01:30

Aneurysm I: Introduction

18
An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
18
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

41
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
41

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Authorship asymmetry at the Women in Thoracic Surgery Inaugural Annual Conference: Gender pairings and senior status disparity.

JTCVS open·2026
Same author

Correction: Grewal et al. Diversity and Representation in Cardiovascular Research: Evidence Gaps, Emerging Models, and Policy Implications. <i>Int. J. Environ. Res. Public Health</i> 2026, <i>23</i>, 241.

International journal of environmental research and public health·2026
Same author

Dissection dimensions differ: Global variability in ascending aortic size challenges universal surgical thresholds.

JTCVS structural and endovascular·2026
Same author

Mendelian Randomization Suggests a Causal Link Between Glycemic Traits and Thoracic Aortic Structures and Diseases.

JACC. Basic to translational science·2026
Same author

Establishing reference values for aortic dimensions in the general Indian population and implications for global standards.

Indian journal of thoracic and cardiovascular surgery·2026
Same author

Beyond the tear: the enduring role of aortic pathology in the era of genomic medicine.

Open heart·2026

Related Experiment Video

Updated: Aug 12, 2025

Novel and Innovative Hybrid Technique for Type A Aortic Dissection
06:26

Novel and Innovative Hybrid Technique for Type A Aortic Dissection

Published on: March 28, 2025

436

Are acute type A aortic dissections atherosclerotic?

Nimrat Grewal1,2,3, Onur Dolmaci1,2, Evert Jansen1

  • 1Department of Cardiothoracic Surgery, Amsterdam University Medical Center, Amsterdam, Netherlands.

Frontiers in Cardiovascular Medicine
|January 26, 2023
PubMed
Summary

Type A aortic dissection (TAAD) patients exhibit minimal progressive atherosclerosis, showing non-progressive intimal lesions unlike controls. This finding is independent of common cardiovascular risk factors.

Keywords:
atherosclerosiscardiovascular riskembryologyintimatype A aortic dissection

More Related Videos

Author Spotlight: Using Point-of-Care Ultrasound for Comprehensive Evaluation of the Abdominal Aorta
07:12

Author Spotlight: Using Point-of-Care Ultrasound for Comprehensive Evaluation of the Abdominal Aorta

Published on: September 8, 2023

2.6K
Precision Ultrasound-guided Stem Cell Delivery for Vascular Repair in Aortic Diseases
05:05

Precision Ultrasound-guided Stem Cell Delivery for Vascular Repair in Aortic Diseases

Published on: June 20, 2025

217

Related Experiment Videos

Last Updated: Aug 12, 2025

Novel and Innovative Hybrid Technique for Type A Aortic Dissection
06:26

Novel and Innovative Hybrid Technique for Type A Aortic Dissection

Published on: March 28, 2025

436
Author Spotlight: Using Point-of-Care Ultrasound for Comprehensive Evaluation of the Abdominal Aorta
07:12

Author Spotlight: Using Point-of-Care Ultrasound for Comprehensive Evaluation of the Abdominal Aorta

Published on: September 8, 2023

2.6K
Precision Ultrasound-guided Stem Cell Delivery for Vascular Repair in Aortic Diseases
05:05

Precision Ultrasound-guided Stem Cell Delivery for Vascular Repair in Aortic Diseases

Published on: June 20, 2025

217

Area of Science:

  • Cardiovascular Research
  • Atherosclerosis Studies
  • Aortic Disease Research

Background:

  • Type A aortic dissection (TAAD) is a severe aortic complication.
  • Predisposing conditions like Marfan syndrome, bicuspid aortic valve, or thoracic aortic aneurysm are linked to TAAD.
  • These conditions feature a thin intimal layer and minimal atherosclerosis, with limited knowledge on TAAD patients' atherosclerosis susceptibility.

Purpose of the Study:

  • To systematically characterize atherosclerotic lesions in patients diagnosed with Type A aortic dissection (TAAD).

Main Methods:

  • Included 51 TAAD patients and 17 controls, assessing cardiovascular risk factors.
  • Aortic tissue sections were stained with Movat pentachrome and hematoxylin eosin.
  • Plaque morphology was classified using the modified AHA classification by Virmani et al.

Main Results:

  • TAAD patients had significantly thinner intima compared to controls (143 ± 126.5 μm vs. 193 ± 132 μm).
  • The majority of TAAD patients displayed non-progressive intimal lesions (e.g., intimal xanthoma), while controls showed progressive lesions.
  • Hypertension was present in 59% of TAAD patients; diabetes and peripheral arterial disease were absent.

Conclusions:

  • TAAD patients demonstrate a notable lack of progressive atherosclerosis.
  • Non-progressive intimal lesions are characteristic of TAAD patients, contrasting with the progressive lesions found in controls.
  • These observations remain consistent regardless of age, sex, or hypertension history.